Exagen Inc. XGN Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by Exagen Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exagen Inc.'s common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Exagen Inc.'s common stock, shares authorized (in shares)?
- Exagen Inc. (XGN) reported common stock, shares authorized (in shares) of $200M in Q1 2026.
- How has Exagen Inc.'s common stock, shares authorized (in shares) changed year-over-year?
- Exagen Inc.'s common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $200M to $200M.
- What is the long-term trend for Exagen Inc.'s common stock, shares authorized (in shares)?
- Over 5 years (2020 to 2025), Exagen Inc.'s common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $200M to $200M.